V710 Lyophilized Formulation

V710 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V710 Lyophilized Formulation, covering 2011-11-21 to 2011-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004) [Phase 1]